CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme
Clinical trial NCT00768911 · UNKNOWN
Trial details
- NCT number
- NCT00768911
- Sponsor
- Adnexus, A Bristol-Myers Squibb R&D Company
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2010-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.